Leif Johansson
- January 11, 2024
- Engineer
Quick Facts
| Full Name | Leif Johansson |
| Date Of Birth | Aug 30, 1951(1951-08-30) |
| Age | 73 |
| Birthplace | Gothenburg |
| Country | Sweden |
| Birth City | Gothenburg |
| Horoscope | Capricorn |
Leif Johansson Biography
| Birthday | Aug 30 |
| Birth Year | 1951 |
Leif Johansson is one of the most popular and richest Engineer who was born on August 30, 1951 in Gothenburg, Gothenburg, Sweden.
Leif Johansson Net Worth
| Net Worth | $5 Million |
| Source Of Income | Engineer |
| House | Living in own house. |
Leif Johansson is one of the richest Engineer from Sweden. According to our analysis, Wikipedia, Forbes & Business Insider, Leif Johansson 's net worth $5 Million. (Last Update: December 11, 2023)
Height, Weight & Body Measurements
Leif Johansson height Not available right now. Leif weight Not Known & body measurements will update soon.
Who is Leif Johansson Dating?
According to our records, Leif Johansson married to Eva Birgitta Fjellman. As of December 1, 2023, Leif Johansson’s is not dating anyone.
Relationships Record : We have no records of past relationships for Leif Johansson. You may help us to build the dating records for Leif Johansson!
Facts & Trivia
Leif Ranked on the list of most popular Engineer. Also ranked in the elit list of famous people born in Sweden. Leif Johansson celebrates birthday on August 30 of every year.
Is Leif Johansson from Israel?
Johansson was born on August 30, 1951, in Gothenburg, Sweden.
Who is the head of Astrazeneca?
Pascal Soriot (Oct 1, 2012–)
Where is the head office of Astrazeneca?
Cambridge, United Kingdom
Who owns AstraZeneca shares?
AstraZeneca is not owned by hedge funds. Looking at our data, we can see that the largest shareholder is Capital Research and Management Company with 8.4% of shares outstanding. Meanwhile, the second and third largest shareholders, hold 8.0% and 6.5%, of the shares outstanding, respectively.
Where is the AstraZeneca Vaccine manufactured?
AstraZeneca takes responsibility for the safety, effectiveness and quality of all the COVID-19 vaccine made in our global supply network of manufacturing facilities across Europe, North, Central and South America, Asia and Australia.